BiotechTube
Home/Cx Precision Medicine/Sid O'Bryant, PhD
SO

Sid O'Bryant, PhD

Scientific Founder

Cx Precision Medicine

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Disorders

Cx Precision Medicine Pipeline

DrugIndicationPhase
NeuroFirst™ Memory TestRule-out of Alzheimer's Dementia in patients >60 with memory complaintsReady to Launch
NeuroFirst™ Parkinson's TestRule-out of Parkinson's Disease in patients >50 with movement disordersLate-Stage Development
AD Subtype testsAlzheimer's Disease subtypingEarly Development
Lewy Body Dementia Rule-OutRule-out of Lewy Body DementiaEarly Development